🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Suzanne L. Topalian

Bloomberg (United States)

ORCID: 0000-0002-0821-8587

Also affiliated with Sidney Kimmel Cancer Center, Sidney Kimmel Comprehensive Cancer Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas

(2023)10.1158/1078-0432.c.6530294
Top 100%
0DataRank
Top 100%0 citations

Evan J. Lipson, Jody E. Hooper, Amanda Zucker, Jungeui Hong, Craig M. Bielski +17 more

Papers

Driven by 18 papers — median percentile 0. Top paper: “Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma”.

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002478
N/A
4.0DataRank · unranked
140 citations

Shailender Bhatia, Evan J. Lipson, William H. Sharfman, Ragini R. Kudchadkar, Andrew S. Brohl +24 more

Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma

Cell Reports Medicine(2020)10.1016/j.xcrm.2020.100139
N/A
2.3DataRank · unranked
79 citations

Daniel C. Bruhm, Noushin Niknafs, James R. White, Xiaoshan M. Shao, John-William Sidhom +19 more

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer Cell(2021)10.1016/j.ccell.2020.11.015
N/A
1.9DataRank · unranked
53 citations

Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodriguez, Petra Ross-Macdonald, Megan Wind-Rotolo +31 more

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Journal of Clinical Oncology(2010)10.1200/jco.2009.26.7609
N/A
1.2DataRank · unranked
2920 citations

Charles G. Drake, Ira Wollner, John D. Powderly, Joel Picus, William H. Sharfman +15 more

Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinoma

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101412
N/A
0.833DataRank · unranked
26 citations

Saumya Jani, Lichen Jing, Heeju Ryu, Ana Jojic, Carolyn Shasha +14 more

Nivolumab (NIVO) + tacrolimus (TACRO) + prednisone (PRED) +/- ipilimumab (IPI) for kidney transplant recipients (KTR) with advanced cutaneous cancers.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9507
N/A
0.434DataRank · unranked
17 citations

Julie E. Stein, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I. Khushalani +13 more

Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2994
N/A
0DataRank · unranked
69 citations

Joshua E. Reuss, Marianna Zahurak, Jiajia Zhang, Zhen Zeng, Janis M. Taube +12 more

Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinoma

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.100947
N/A
0DataRank · unranked
27 citations

Evan J. Lipson, Ludmila Danilova, Suzanne L. Topalian, Jaroslaw Jedrych, Ezra Baraban +10 more

Data from The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas

(2023)10.1158/1078-0432.c.6530294
Top 100%
0DataRank
Top 100%0 citations

Evan J. Lipson, Jody E. Hooper, Amanda Zucker, Jungeui Hong, Craig M. Bielski +17 more

Data from Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer

(2023)10.1158/1078-0432.c.6533117.v1
N/A
0DataRank · unranked
0 citations

Joshua E. Reuss, Marianna Zahurak, Jiajia Zhang, Zhen Zeng, Janis M. Taube +12 more

T antigen–specific CD8+ T cells associate with PD-1 blockade response in virus-positive Merkel cell carcinoma

Journal of Clinical Investigation(2024)10.1172/jci177082
N/A
0DataRank · unranked
15 citations

Candice D. Church, Ana Micaela Carnaz Simões, Marcus Svensson, Amalie Kai Bentzen, Siri Tvingsholm +7 more

Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: a joint SITC and INMC effort

Annals of Oncology(2025)10.1016/j.annonc.2025.10.018
N/A
0DataRank · unranked
8 citations

Richard A. Scolyer, Elizabeth M. Burton, Klaus J. Busam, Kuang Yu Chen, Ashley Cimino‐Mathews +18 more

A minimal gene set characterizes TIL specific for diverse tumor antigens across different cancer types

Nature Communications(2025)10.1038/s41467-024-55059-3
N/A
0DataRank · unranked
13 citations

Tianbei Zhang, Jiajia Zhang, Shuai Li, Sydney Connor, Boyang Zhang +14 more

Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001282
N/A
0DataRank · unranked
166 citations

Valsamo Anagnostou, Tricia R. Cottrell, Kellie N. Smith, Franco Verde, Marianna Zahurak +27 more

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer Cell(2020)10.1016/j.ccell.2020.08.005
N/A
0DataRank · unranked
389 citations

Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodríguez, Petra Ross‐Macdonald, Megan Wind‐Rotolo +31 more

Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas

Cancer Immunology Immunotherapy(2020)10.1007/s00262-020-02747-w
N/A
0DataRank · unranked
42 citations

Pia Kvistborg, Julie E. Stein, Elizabeth L. Engle, Tracee L. McMiller, Lisa M. Rooper +8 more

Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade

Science(2021)10.1126/science.aba2609
N/A
0DataRank · unranked
206 citations

Nicolás A. Giraldo, Benjamin Green, Tricia R. Cottrell, Julie E. Stein, Elizabeth L. Engle +32 more

Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy

Cancer Cell(2023)10.1016/j.ccell.2023.07.011
N/A
0DataRank · unranked
288 citations

Patrick M. Forde, Leisha A. Emens, Mark Yarchoan, Kellie N. Smith, Drew M. Pardoll +1 more